Alterity Therapeutics Limited
ATHE
Positions held
Your positionsATHE isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $55.90M | Enterprise value | $18.78M | Trailing P/E | — | Forward P/E | -3.21 |
| PEG | — | Price / book | 1.88 | Beta | -0.01 | Dividend yield | 0.00% |
| Revenue growth | -79.0% | Earnings growth | — | Gross margin | 92.7% | Operating margin | -18.2% |
| Profit margin | 0.0% | ROE | -55.0% | ROA | -34.1% | Debt / equity | 0.00 |
| Current ratio | 14.52 | Free cash flow | -$14.74M | Analyst recommendation | none | Mean target | $13.25 |
| 52w high | $5.89 | 52w low | $2.66 |
Quarterly
No data yet.
Yearly (6y)
| 2026 | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$23.4M | -$12.1M | -$19.1M | -$13.8M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$25.1M | -$12.5M | -$19.6M | -$14.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-16 · Lake Street Initiates Alterity Therapeutics at Buy With $10 Price Target
2026-09-03 · Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
2026-08-12 · Alterity Therapeutics Announces Granting of New U.S. Composition of Matter Patent for ATH434
2026-08-06 · Alterity Therapeutics to Present at the 46th Annual Canaccord Genuity Growth Conference
2026-07-30 · Alterity Therapeutics Releases Appendix 4C – Q4 FY26 Quarterly Cash Flow Report & Corporate Update
2026-07-21 · Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026
Price (daily)
Full chart · RSI · MACD · patterns